Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian population

Authors

  • Éric Vigneault CHU de Québec-Université Laval Research Center Department of Radiation Oncology, CHU de Québec-Université Laval
  • Josée Savard CHU de Québec-Université Laval Research Center Université Laval Cancer Research Centre School of Psychology, Université Laval
  • Marie-Hélène Savard CHU de Québec-Université Laval research center Université Laval Cancer Research Centre
  • Hans Ivers CHU de Québec-Université Laval Research Center Université Laval Cancer Research Centre School of Psychology, Université Laval
  • Philippe Després CHU de Québec-Université Laval Research Center Department of Radiation Oncology, CHU de Québec-Université Laval Université Laval Cancer Research Centre Département de physique, de génie physique et d’optique, Université Laval
  • William Foster Department of Radiation Oncology, CHU de Québec-Université Laval
  • André-Guy Martin CHU de Québec-Université Laval Research Center Department of Radiation Oncology, CHU de Québec-Université Laval
  • Vincent Fradet CHU de Québec-Université Laval Research Center Université Laval Cancer Research Centre Department of Surgery, Université Laval

DOI:

https://doi.org/10.5489/cuaj.4428

Abstract

Introduction: This study aims to empirically validate the French- Canadian version of the Expanded Prostate Cancer Index Composite (EPIC), a measure of health-related quality of life for prostate cancer patients.

Methods: Two hundred fifty-one participants completed a battery of self-report scales, including the French-Canadian version of the EPIC, after having received radiation therapy or radical prostatectomy for prostate cancer.

Results: The internal consistency for the urinary incontinence, bowel, and sexual domains of the EPIC-26 was high (Cronbach’s alpha coefficients from 0.80‒0.92), while coefficients for the urinary irritation/obstruction (0.59) and hormonal (0.67) domains were lower. Item-total correlations (rs=0.15‒0.85), and temporal stability (rs=0.72‒0.93) generally supported the reliability of the instrument. The five-factor structure of the EPIC-26 was confirmed for the most part. The construct validity of the instrument was also supported by high correlations obtained between each domain and measures assessing similar constructs (rs=-0.56‒0.83). The EPIC also showed an excellent sensitivity to change with significant differences obtained on EPIC scores (all p<0.05) between pre- and post-prostate cancer treatment.

Conclusions: The psychometric qualities of the French-Canadian version of the EPIC are well-supported, thus providing a valid tool to assess health-related quality of life in prostate cancer patients.

Downloads

Download data is not yet available.

Downloads

Published

2017-11-01

How to Cite

Vigneault, Éric, Savard, J., Savard, M.-H., Ivers, H., Després, P., Foster, W., Martin, A.-G., & Fradet, V. (2017). Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian population. Canadian Urological Association Journal, 11(12), 404–10. https://doi.org/10.5489/cuaj.4428

Issue

Vol. 11 No. 12 (2017): CUAJ December

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.